2012
DOI: 10.1007/s12325-012-0032-x
|View full text |Cite
|
Sign up to set email alerts
|

Telmisartan at 80 mg/Day Increases High-Molecular-Weight Adiponectin Levels and Improves Insulin Resistance in Diabetic Patients

Abstract: In diabetic patients with hypertension, high-dose telmisartan increased HMW adiponectin levels and improved insulin resistance through activation of PPAR-gamma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
16
0
2

Year Published

2013
2013
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(19 citation statements)
references
References 24 publications
1
16
0
2
Order By: Relevance
“…Furthermore, in metabolism olmesartan has an inflammatory effect as pleiotropic effects [15][16][17], while telmisartan has reported to increase serum adiponectine as a partial PPAR-γ agonist at the highest dose [18]. Therefore, a crossover study was performed to compare the effects of olmesartan (40 mg/day) and telmisartan (80 mg/day) on the blood pressure and metabolic profile.…”
Section: Methodsmentioning
confidence: 99%
“…Furthermore, in metabolism olmesartan has an inflammatory effect as pleiotropic effects [15][16][17], while telmisartan has reported to increase serum adiponectine as a partial PPAR-γ agonist at the highest dose [18]. Therefore, a crossover study was performed to compare the effects of olmesartan (40 mg/day) and telmisartan (80 mg/day) on the blood pressure and metabolic profile.…”
Section: Methodsmentioning
confidence: 99%
“…RAS is recognized as contributing to the development of osteoporosis independently of hypertension [17][19], and a blockage of this system either at the level of angiotensin enzyme inhibitor (ACEI) or at the level of angiotensin receptors proved to be beneficial for bone [20], [21]. Beside its anti-hypertensive activity, TEL has a unique ability to bind and activate PPARγ [22], [23] and has a beneficial effects on insulin sensitivity in humans [24][26] and rodents [27]. As compared to full agonists, pioglitazone and ROSI, TEL binds PPARγ in a different fashion which results in a distinct pattern of cofactors recruitment and different pharmacological effects [28].…”
Section: Introductionmentioning
confidence: 99%
“…There were no intergroup differences in BMI in 10 studies 19-24,28-31 , and in waist circumference in 5 studies16,18,22,24,30 (WMD = -0.16 kg/m 2 , 95% CI = -0.65 to 0.32, P chi 2 = 0.004, I 2 = 62%; WMD = -1.92 cm, 95% CI = -4.68 to 0.84, P chi 2 = 0.03, I 2 = 62%, respectively). TC was evaluated in 13 studies 16-25,28-31 , TG in 13 16-24,28-31 , LDL in 916- 19,21,24,28,29,31 , and HDL-C in 12[16][17][18][19][21][22][23][24][28][29][30][31] . TC showed a significant difference between the 2 groups (SMD = -0.24, 95% CI = -0.45 to -0.03, P chi 2 = 0.0002, I 2 = 67%;figure 3).…”
mentioning
confidence: 99%